{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:47:28Z","timestamp":1793818048184,"version":"4.6.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82173770"],"award-info":[{"award-number":["No. 82173770"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03190-8","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:03:32Z","timestamp":1740222212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Polyzwitterion-branched polycholic acid nanocarriers based oral delivery insulin for long-term glucose and metabolic regulation in diabetes mellitus"],"prefix":"10.1186","volume":"23","author":[{"given":"Wenkai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-En","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"3190_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabete Res Clin Pract. 2022;183: 109119.","journal-title":"Diabete Res Clin Pract"},{"key":"3190_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m997","volume":"369","author":"Y Li","year":"2020","unstructured":"Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American diabetes association: national cross sectional study. BMJ. 2020;369: m997.","journal-title":"BMJ"},{"key":"3190_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","volume":"22","author":"TH Baryakova","year":"2023","unstructured":"Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov. 2023;22:387\u2013409.","journal-title":"Nat Rev Drug Discov"},{"key":"3190_CR4","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.2337\/dc23-S009","volume":"46","author":"NA ElSayed","year":"2022","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142023. Diabete Care. 2022;46:S140-157.","journal-title":"Diabete Care"},{"key":"3190_CR5","unstructured":"US Food and Drug Administration. Novel drug approvals for 2023. FDA. 2023. https:\/\/www.fda.gov\/drugs\/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products\/novel-drug-approvals-2023."},{"key":"3190_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122312","volume":"302","author":"RJ Kulchar","year":"2023","unstructured":"Kulchar RJ, Singh R, Ding S, Alexander E, Leong KW, Daniell H. Delivery of biologics: topical administration. Biomaterials. 2023;302: 122312.","journal-title":"Biomaterials"},{"key":"3190_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41578-019-0156-6","volume":"5","author":"TD Brown","year":"2020","unstructured":"Brown TD, Whitehead KA, Mitragotri S. Materials for oral delivery of proteins and peptides. Nat Rev Mater. 2020;5:127\u201348.","journal-title":"Nat Rev Mater"},{"key":"3190_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","volume":"19","author":"DJ Drucker","year":"2020","unstructured":"Drucker DJ. Advances in oral peptide therapeutics. Nat Rev Drug Discov. 2020;19:277\u201389.","journal-title":"Nat Rev Drug Discov"},{"key":"3190_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2337\/diab.36.8.959","volume":"36","author":"GM Argoud","year":"1987","unstructured":"Argoud GM, Schade DS, Eaton RP. Insulin suppresses its own secretion in vivo. Diabetes. 1987;36:959\u201362.","journal-title":"Diabetes"},{"key":"3190_CR10","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","volume":"45","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycemia in type 2 diabetes, 2022. a consensus report by the american diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care. 2022;45:2753\u201386.","journal-title":"Diabetes Care."},{"key":"3190_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0140-6736(21)01919-X","volume":"399","author":"I Lingvay","year":"2022","unstructured":"Lingvay I, Sumithran P, Cohen RV, le Roux CW. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Lancet. 2022;399:394\u2013405.","journal-title":"Lancet"},{"key":"3190_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114097","volume":"182","author":"S Haddadzadegan","year":"2022","unstructured":"Haddadzadegan S, Dorkoosh F, Bernkop-Schn\u00fcrch A. Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev. 2022;182: 114097.","journal-title":"Adv Drug Deliv Rev"},{"key":"3190_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","volume":"64","author":"LM Ensign","year":"2012","unstructured":"Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64:557\u201370.","journal-title":"Adv Drug Deliv Rev"},{"key":"3190_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.mattod.2023.01.002","volume":"62","author":"J Ouyang","year":"2023","unstructured":"Ouyang J, Zhang Z, Deng B, Liu J, Wang L, Liu H, et al. Oral drug delivery platforms for biomedical applications. Mater Today. 2023;62:296\u2013326.","journal-title":"Mater Today"},{"key":"3190_CR15","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1039\/D0BM01151G","volume":"8","author":"T Tong","year":"2020","unstructured":"Tong T, Wang L, You X, Wu J. Nano and microscale delivery platforms for enhanced oral peptide\/protein bioavailability. Biomater Sci. 2020;8:5804\u201323.","journal-title":"Biomater Sci"},{"key":"3190_CR16","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1039\/D0NR06104B","volume":"13","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Xiong GM, Ali Y, Boehm BO, Huang YY, Venkatraman S. Layer-by-layer coated nanoliposomes for oral delivery of insulin. Nanoscale. 2021;13:776\u201389.","journal-title":"Nanoscale"},{"key":"3190_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119488","volume":"585","author":"L Wright","year":"2020","unstructured":"Wright L, Barnes TJ, Prestidge CA. Oral delivery of protein-based therapeutics: gastroprotective strategies, physiological barriers and in vitro permeability prediction. Int J Pharm. 2020;585: 119488.","journal-title":"Int J Pharm"},{"key":"3190_CR18","doi-asserted-by":"publisher","first-page":"2306081","DOI":"10.1002\/adma.202306081","volume":"36","author":"B Deng","year":"2024","unstructured":"Deng B, Liu S, Wang Y, Ali B, Kong N, Xie T, et al. Oral nanomedicine: challenges and opportunities. Adv Mater. 2024;36:2306081.","journal-title":"Adv Mater"},{"key":"3190_CR19","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cphy.c120023","volume":"3","author":"JYL Chiang","year":"2013","unstructured":"Chiang JYL. Bile acid metabolism and signaling. Compr Physiol. 2013;3:1191\u2013212.","journal-title":"Compr Physiol"},{"key":"3190_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/0004563218817798","volume":"56","author":"ER McGlone","year":"2019","unstructured":"McGlone ER, Bloom SR. Bile acids and the metabolic syndrome. Ann Clin Biochem. 2019;56:326\u201337.","journal-title":"Ann Clin Biochem"},{"key":"3190_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tem.2017.11.002","volume":"29","author":"A Molinaro","year":"2018","unstructured":"Molinaro A, Wahlstr\u00f6m A, Marschall HU. Role of bile acids in metabolic control. Trends Endocrinol Metab. 2018;29:31\u201341.","journal-title":"Trends Endocrinol Metab"},{"key":"3190_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","volume":"33","author":"X Zheng","year":"2021","unstructured":"Zheng X, Chen T, Jiang R, Zhao A, Wu Q, Kuang J, et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab. 2021;33:791-803.e7.","journal-title":"Cell Metab"},{"key":"3190_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/MOL.0000000000000597","volume":"30","author":"O Ch\u00e1vez-Talavera","year":"2019","unstructured":"Ch\u00e1vez-Talavera O, Haas J, Grzych G, Tailleux A, Staels B. Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell? Curr Opin Lipidol. 2019;30:244.","journal-title":"Curr Opin Lipidol"},{"key":"3190_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s42255-022-00559-z","volume":"4","author":"A Perino","year":"2022","unstructured":"Perino A, Schoonjans K. Metabolic messengers: bile acids. Nat Metab. 2022;4:416\u201323.","journal-title":"Nat Metab"},{"key":"3190_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature04330","volume":"439","author":"M Watanabe","year":"2006","unstructured":"Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439:484\u20139.","journal-title":"Nature"},{"key":"3190_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4093\/dmj.2019.0043","volume":"43","author":"JM Ferrell","year":"2019","unstructured":"Ferrell JM, Chiang JYL. Understanding bile acid signaling in diabetes: from pathophysiology to therapeutic targets. Diabete Metab J. 2019;43:257\u201372.","journal-title":"Diabete Metab J"},{"key":"3190_CR27","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","volume":"62","author":"M Mueller","year":"2015","unstructured":"Mueller M, Thorell A, Claudel T, Jha P, Koefeler H, Lackner C, et al. Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity. J Hepatol. 2015;62:1398\u2013404.","journal-title":"J Hepatol"},{"key":"3190_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jconrel.2020.07.034","volume":"327","author":"F Deng","year":"2020","unstructured":"Deng F, Bae YH. Bile acid transporter-mediated oral drug delivery. J Control Releas. 2020;327:100\u201316.","journal-title":"J Control Releas"},{"key":"3190_CR29","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/17425247.2016.1178233","volume":"13","author":"C Faustino","year":"2016","unstructured":"Faustino C, Serafim C, Rijo P, Reis CP. Bile acids and bile acid derivatives: use in drug delivery systems and as therapeutic agents. Expert Opin Drug Deliv. 2016;13:1133\u201348.","journal-title":"Expert Opin Drug Deliv"},{"key":"3190_CR30","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1021\/mp400117m","volume":"10","author":"F Le D\u00e9v\u00e9dec","year":"2013","unstructured":"Le D\u00e9v\u00e9dec F, Strandman S, Hildgen P, Leclair G, Zhu XX. PEGylated bile acids for use in drug delivery systems: enhanced solubility and bioavailability of itraconazole. Mol Pharm. 2013;10:3057\u201366.","journal-title":"Mol Pharm"},{"key":"3190_CR31","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/j.xphs.2019.01.027","volume":"108","author":"S Wu","year":"2019","unstructured":"Wu S, Sun C. A delivery system for oral administration of proteins\/peptides through bile acid transport channels. J Pharm Sci. 2019;108:2143\u201352.","journal-title":"J Pharm Sci"},{"key":"3190_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2022.102629","volume":"48","author":"F Deng","year":"2023","unstructured":"Deng F, Bae YH. Effect of modification of polystyrene nanoparticles with different bile acids on their oral transport. Nanomedicine. 2023;48: 102629.","journal-title":"Nanomedicine"},{"key":"3190_CR33","doi-asserted-by":"publisher","first-page":"2201414","DOI":"10.1002\/advs.202201414","volume":"9","author":"F Deng","year":"2022","unstructured":"Deng F, Kim KS, Moon J, Bae YH. Bile acid conjugation on solid nanoparticles enhances asbt-mediated endocytosis and chylomicron pathway but weakens the transcytosis by inducing transport flow in a cellular negative feedback loop. Adv Sci. 2022;9:2201414.","journal-title":"Adv Sci"},{"key":"3190_CR34","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1002\/smll.201303540","volume":"10","author":"KP Garc\u00eda","year":"2014","unstructured":"Garc\u00eda KP, Zarschler K, Barbaro L, Barreto JA, O\u2019Malley W, Spiccia L, et al. Zwitterionic-coated \u201cstealth\u201d nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system. Small. 2014;10:2516\u201329.","journal-title":"Small"},{"key":"3190_CR35","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.csbj.2020.07.015","volume":"18","author":"LY Zhou","year":"2020","unstructured":"Zhou LY, Zhu YH, Wang XY, Shen C, Wei XW, Xu T, et al. Novel zwitterionic vectors: Multi-functional delivery systems for therapeutic genes and drugs. Comput Struct Biotechnol J. 2020;18:1980\u201399.","journal-title":"Comput Struct Biotechnol J"},{"key":"3190_CR36","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41551-021-00701-4","volume":"5","author":"S Chen","year":"2021","unstructured":"Chen S, Zhong Y, Fan W, Xiang J, Wang G, Zhou Q, et al. Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion\u2013drug conjugates with cell-membrane affinity. Nat Biomed Eng. 2021;5:1019\u201337.","journal-title":"Nat Biomed Eng"},{"key":"3190_CR37","doi-asserted-by":"publisher","first-page":"21321","DOI":"10.1021\/jacs.1c09822","volume":"143","author":"S Liu","year":"2021","unstructured":"Liu S, Wang X, Yu X, Cheng Q, Johnson LT, Chatterjee S, et al. Zwitterionic phospholipidation of cationic polymers facilitates systemic mrna delivery to spleen and lymph nodes. J Am Chem Soc. 2021;143:21321\u201330.","journal-title":"J Am Chem Soc"},{"key":"3190_CR38","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2021.01.028","volume":"331","author":"A Biosca","year":"2021","unstructured":"Biosca A, Cabanach P, Abdulkarim M, Gumbleton M, G\u00f3mez-Canela C, Ram\u00edrez M, et al. Zwitterionic self-assembled nanoparticles as carriers for Plasmodium targeting in malaria oral treatment. J Control Release. 2021;331:364\u201375.","journal-title":"J Control Release"},{"key":"3190_CR39","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1021\/acs.biomac.0c00497","volume":"21","author":"A Erfani","year":"2020","unstructured":"Erfani A, Seaberg J, Aichele CP, Ramsey JD. Interactions between biomolecules and zwitterionic moieties: a review. Biomacromol. 2020;21:2557\u201373.","journal-title":"Biomacromol"},{"key":"3190_CR40","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1021\/acsnano.2c08434","volume":"17","author":"H Fang","year":"2023","unstructured":"Fang H, Chen L, Deng Z, Gao Y, Yang Y, Chen Q, et al. In situ polymerization of zwitterions on therapeutic proteins to enable their effective oral delivery. ACS Nano. 2023;17:1128\u201343.","journal-title":"ACS Nano"},{"key":"3190_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-024-01764-5","author":"K Ji","year":"2024","unstructured":"Ji K, Wei X, Kahkoska AR, Zhang J, Zhang Y, Xu J, et al. An orally administered glucose-responsive polymeric complex for high-efficiency and safe delivery of insulin in mice and pigs. Nat Nanotechnol. 2024. https:\/\/doi.org\/10.1038\/s41565-024-01764-5.","journal-title":"Nat Nanotechnol"},{"key":"3190_CR42","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41565-020-0693-6","volume":"15","author":"X Han","year":"2020","unstructured":"Han X, Lu Y, Xie J, Zhang E, Zhu H, Du H, et al. Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions. Nat Nanotechnol. 2020;15:605\u201314.","journal-title":"Nat Nanotechnol"},{"key":"3190_CR43","doi-asserted-by":"publisher","first-page":"25444","DOI":"10.1021\/acsami.6b08183","volume":"8","author":"W Shan","year":"2016","unstructured":"Shan W, Zhu X, Tao W, Cui Y, Liu M, Wu L, et al. Enhanced oral delivery of protein drugs using zwitterion-functionalized nanoparticles to overcome both the diffusion and absorption barriers. ACS Appl Mater Interfac. 2016;8:25444\u201353.","journal-title":"ACS Appl Mater Interfac"},{"key":"3190_CR44","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1016\/j.biomaterials.2013.04.052","volume":"34","author":"X Zeng","year":"2013","unstructured":"Zeng X, Tao W, Mei L, Huang L, Tan C, Feng S-S. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials. 2013;34:6058\u201367.","journal-title":"Biomaterials"},{"key":"3190_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.10.022","volume":"151","author":"W Fan","year":"2018","unstructured":"Fan W, Xia D, Zhu Q, Li X, He S, Zhu C, et al. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery. Biomaterials. 2018;151:13\u201323.","journal-title":"Biomaterials"},{"key":"3190_CR46","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41551-021-00791-0","volume":"5","author":"JS Lee","year":"2021","unstructured":"Lee JS, Han P, Chaudhury R, Khan S, Bickerton S, McHugh MD, et al. Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin. Nat Biomed Eng. 2021;5:983\u201397.","journal-title":"Nat Biomed Eng"},{"key":"3190_CR47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jconrel.2022.02.004","volume":"343","author":"H Qian","year":"2022","unstructured":"Qian H, Wang K, Lv M, Zhao C, Wang H, Wen S, et al. Recent advances on next generation of polyzwitterion-based nano-vectors for targeted drug delivery. J Control Release. 2022;343:492\u2013505.","journal-title":"J Control Release"},{"key":"3190_CR48","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/adma.200901407","volume":"22","author":"S Jiang","year":"2010","unstructured":"Jiang S, Cao Z. Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications. Adv Mater. 2010;22:920\u201332.","journal-title":"Adv Mater"},{"key":"3190_CR49","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1021\/acs.langmuir.0c03217","volume":"37","author":"S Zeng","year":"2021","unstructured":"Zeng S, Quan X, Zhu H, Sun D, Miao Z, Zhang L, et al. Computer simulations on a ph-responsive anticancer drug delivery system using zwitterion-grafted polyamidoamine dendrimer unimolecular micelles. Langmuir. 2021;37:1225\u201334.","journal-title":"Langmuir"},{"key":"3190_CR50","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1002\/anie.200907079","volume":"49","author":"Z Cao","year":"2010","unstructured":"Cao Z, Yu Q, Xue H, Cheng G, Jiang S. Nanoparticles for drug delivery prepared from amphiphilic plga zwitterionic block copolymers with sharp contrast in polarity between two blocks. Angew Chem Int Ed Engl. 2010;49:3771\u20136.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3190_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119521","volume":"586","author":"T Ryujin","year":"2020","unstructured":"Ryujin T, Shimizu T, Miyahara R, Asai D, Shimazui R, Yoshikawa T, et al. Blood retention and antigenicity of polycarboxybetaine-modified liposomes. Int Int J Pharm. 2020;586: 119521.","journal-title":"Int Int J Pharm"},{"key":"3190_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jconrel.2019.12.038","volume":"319","author":"TD Langridge","year":"2020","unstructured":"Langridge TD, Gemeinhart RA. Toward understanding polymer micelle stability: density ultracentrifugation offers insight into polymer micelle stability in human fluids. J Control Release. 2020;319:157\u201367.","journal-title":"J Control Release"},{"key":"3190_CR53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejps.2014.07.007","volume":"63","author":"S Huang","year":"2014","unstructured":"Huang S, Yu X, Yang L, Song F, Chen G, Lv Z, et al. The efficacy of nimodipine drug delivery using mPEG-PLA micelles and mPEG-PLA\/TPGS mixed micelles. Eur J Pharm Sci. 2014;63:187\u201398.","journal-title":"Eur J Pharm Sci"},{"key":"3190_CR54","doi-asserted-by":"publisher","first-page":"13217","DOI":"10.1021\/jp074990n","volume":"111","author":"X Liang","year":"2007","unstructured":"Liang X, Guo C, Ma J, Wang J, Chen S, Liu H. Temperature-dependent aggregation and disaggregation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) block copolymer in aqueous solution. J Phys Chem B. 2007;111:13217\u201320.","journal-title":"J Phys Chem B"},{"key":"3190_CR55","first-page":"757","volume":"15","author":"C Cheng","year":"2012","unstructured":"Cheng C, Qu G, Wei J, Yu T, Ding W. Thermodynamics of micellization of sulfobetaine surfactants in aqueous solution. J Colloid Interfac Sci. 2012;15:757\u201363.","journal-title":"J Colloid Interfac Sci"},{"key":"3190_CR56","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/bcpt.12342","volume":"116","author":"M Boegh","year":"2015","unstructured":"Boegh M, Nielsen HM. Mucus as a barrier to drug delivery - understanding and mimicking the barrier properties. Basic Clin Pharmacol Toxicol. 2015;116:179\u201386.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3190_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.colsurfb.2015.07.038","volume":"135","author":"BH Bajka","year":"2015","unstructured":"Bajka BH, Rigby NM, Cross KL, Macierzanka A, Mackie AR. The influence of small intestinal mucus structure on particle transport ex vivo. Colloid Surf B Biointerfac. 2015;135:73\u201380.","journal-title":"Colloid Surf B Biointerfac"},{"key":"3190_CR58","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","volume":"61","author":"SK Lai","year":"2009","unstructured":"Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61:158\u201371.","journal-title":"Adv Drug Deliv Rev"},{"key":"3190_CR59","doi-asserted-by":"publisher","first-page":"2102044","DOI":"10.1002\/adma.202102044","volume":"33","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Chen Z, Zhao D, Li D, He C, Chen X. A pH-Triggered self-unpacking capsule containing zwitterionic hydrogel-coated MOF nanoparticles for efficient oral exendin-4 delivery. Adv Mater. 2021;33:2102044.","journal-title":"Adv Mater"},{"key":"3190_CR60","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1016\/j.biomaterials.2013.04.053","volume":"34","author":"B He","year":"2013","unstructured":"He B, Lin P, Jia Z, Du W, Qu W, Yuan L, et al. The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells. Biomaterials. 2013;34:6082\u201398.","journal-title":"Biomaterials"},{"key":"3190_CR61","doi-asserted-by":"publisher","first-page":"2109189","DOI":"10.1002\/adma.202109189","volume":"34","author":"W Fan","year":"2022","unstructured":"Fan W, Xiang J, Zhou Z, Tang J, Xie T, Li Z, et al. Mucus penetrating and cell-binding polyzwitterionic micelles as potent oral nanomedicine for cancer drug delivery. Adv Mater. 2022;34:2109189.","journal-title":"Adv Mater"},{"key":"3190_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102300","volume":"30","author":"D Montizaan","year":"2020","unstructured":"Montizaan D, Yang K, Reker-Smit C, Salvati A. Comparison of the uptake mechanisms of zwitterionic and negatively charged liposomes by HeLa cells. Nanomedicine. 2020;30: 102300.","journal-title":"Nanomedicine"},{"key":"3190_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm4677","author":"J-J Zou","year":"2022","unstructured":"Zou J-J, Wei G, Xiong C, Yu Y, Li S, Hu L, et al. Efficient oral insulin delivery enabled by transferrin-coated acid-resistant metal-organic framework nanoparticles. Sci Adv. 2022. https:\/\/doi.org\/10.1126\/sciadv.abm4677.","journal-title":"Sci Adv"},{"key":"3190_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112946","volume":"150","author":"K Szkudelska","year":"2022","unstructured":"Szkudelska K, Szkudelski T. The anti-diabetic potential of betaine. Mechanisms of action in rodent models of type 2 diabetes. Biomed Pharmacother. 2022;150: 112946.","journal-title":"Biomed Pharmacother"},{"key":"3190_CR65","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1681\/ASN.2014121271","volume":"27","author":"XX Wang","year":"2016","unstructured":"Wang XX, Edelstein MH, Gafter U, Qiu L, Luo Y, Dobrinskikh E, et al. G protein-coupled bile acid Receptor TGR5 activation inhibits kidney disease in obesity and diabetes. J Am Soc Nephro. 2016;27:1362.","journal-title":"J Am Soc Nephro"},{"key":"3190_CR66","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","volume":"15","author":"CK Glass","year":"2012","unstructured":"Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15:635\u201345.","journal-title":"Cell Metab"},{"key":"3190_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55:31\u201355.","journal-title":"Immunity"},{"key":"3190_CR68","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Ch\u00e1vez-Talavera","year":"2017","unstructured":"Ch\u00e1vez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology. 2017;152:1679-1694.e3.","journal-title":"Gastroenterology"},{"key":"3190_CR69","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","volume":"17","author":"TQ de Aguiar Vallim","year":"2013","unstructured":"de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17:657\u201369.","journal-title":"Cell Metab"},{"key":"3190_CR70","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.cmet.2015.07.002","volume":"22","author":"EPM Broeders","year":"2015","unstructured":"Broeders EPM, Nascimento EBM, Havekes B, Brans B, Roumans KHM, Tailleux A, et al. The bile acid chenodeoxycholic acid increases human brown adipose tissue activity. Cell Metab. 2015;22:418\u201326.","journal-title":"Cell Metab"},{"key":"3190_CR71","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/nm.3361","volume":"19","author":"M Harms","year":"2013","unstructured":"Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med. 2013;19:1252\u201363.","journal-title":"Nat Med"},{"key":"3190_CR72","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41467-017-02068-0","volume":"9","author":"LA Velazquez-Villegas","year":"2018","unstructured":"Velazquez-Villegas LA, Perino A, Lemos V, Zietak M, Nomura M, Pols TWH, et al. TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue. Nat Commun. 2018;9:245.","journal-title":"Nat Commun"},{"key":"3190_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl7398","author":"JC Bruening","year":"2023","unstructured":"Bruening JC, Fenselau H. Integrative neurocircuits that control metabolism and food intake. Science. 2023. https:\/\/doi.org\/10.1126\/science.abl7398.","journal-title":"Science"},{"key":"3190_CR74","first-page":"273","volume":"6","author":"W Xia","year":"2024","unstructured":"Xia W, Veeragandham P, Cao Y, Xu Y, Rhyne TE, Qian J, et al. Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation. Cell Metab. 2024;6:273\u201389.","journal-title":"Cell Metab"},{"key":"3190_CR75","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2021.12.012","volume":"34","author":"S Klein","year":"2022","unstructured":"Klein S, Gastaldelli A, Yki-J\u00e4rvinen H, Scherer PE. Why does obesity cause diabetes? Cell Metab. 2022;34:11\u201320.","journal-title":"Cell Metab"},{"key":"3190_CR76","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI29881","volume":"117","author":"CN Lumeng","year":"2007","unstructured":"Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117:175\u201384.","journal-title":"J Clin Invest"},{"key":"3190_CR77","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1172\/JCI76289","volume":"124","author":"A Perino","year":"2014","unstructured":"Perino A, Pols TWH, Nomura M, Stein S, Pellicciari R, Schoonjans K. TGR5 reduces macrophage migration through mTOR-induced C\/EBP\u03b2 differential translation. J Clin Invest. 2014;124:5424\u201336.","journal-title":"J Clin Invest"},{"key":"3190_CR78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00710-4","volume":"7","author":"X Wen","year":"2022","unstructured":"Wen X, Zhang B, Wu B, Xiao H, Li Z, Li R, et al. Signaling pathways in obesity: mechanisms and therapeutic interventions. Sig Transduct Target Ther. 2022;7:1\u201331.","journal-title":"Sig Transduct Target Ther"},{"key":"3190_CR79","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41590-023-01479-0","volume":"24","author":"T Chavakis","year":"2023","unstructured":"Chavakis T, Alexaki VI, Ferrante AW. Macrophage function in adipose tissue homeostasis and metabolic inflammation. Nat Immunol. 2023;24:757\u201366.","journal-title":"Nat Immunol"},{"key":"3190_CR80","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-020-20315-9","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Tang B, Long L, Luo P, Xiang W, Li X, et al. Improvement of obesity-associated disorders by a small-molecule drug targeting mitochondria of adipose tissue macrophages. Nat Commun. 2021;12:102.","journal-title":"Nat Commun"},{"key":"3190_CR81","first-page":"189","volume":"1","author":"ET Chouchani","year":"2019","unstructured":"Chouchani ET, Kajimura S. Metabolic adaptation and maladaptation in adipose tissue. Nat Med. 2019;1:189\u2013200.","journal-title":"Nat Med"},{"key":"3190_CR82","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nm.2001","volume":"15","author":"S Winer","year":"2009","unstructured":"Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med. 2009;15:921\u20139.","journal-title":"Nat Med"},{"key":"3190_CR83","doi-asserted-by":"publisher","first-page":"9311","DOI":"10.1021\/acsnano.3c06001","volume":"18","author":"Q Li","year":"2024","unstructured":"Li Q, Byun J, Choi J, Park J, Lee J, Oh Y-K. Nanomodulator-mediated restructuring of adipose tissue immune microenvironments for antiobesity treatment. ACS Nano. 2024;18:9311\u201330.","journal-title":"ACS Nano"},{"key":"3190_CR84","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/cells8030253","volume":"8","author":"Y-S Chen","year":"2019","unstructured":"Chen Y-S, Liu H-M, Lee T-Y. Ursodeoxycholic acid regulates hepatic energy homeostasis and white adipose tissue macrophages polarization in leptin-deficiency obese Mice. Cells. 2019;8:253.","journal-title":"Cells"},{"key":"3190_CR85","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","volume":"33","author":"BL Clifford","year":"2021","unstructured":"Clifford BL, Sedgeman LR, Williams KJ, Morand P, Cheng A, Jarrett KE, et al. FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption. Cell Metab. 2021;33:1671-1684.e4.","journal-title":"Cell Metab"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03190-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03190-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03190-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T11:03:39Z","timestamp":1740222219000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03190-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3190"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03190-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving animals were conducted according to the ethical policies and procedures approved by the ethics committee of Institutional Animal Care and Use Committee (IACUC) of Shanghai Jiao Tong University (Approval no. A2023207-001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}